Veradigm Free Cash Flow 2010-2022 | MDRX
Veradigm free cash flow from 2010 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Veradigm Annual Free Cash Flow | |
|---|---|
| 2022 | 83.30 |
| 2021 | -118.00 |
| 2020 | -149.04 |
| 2019 | -73.51 |
| 2018 | -65.91 |
| 2017 | 122.42 |
| 2016 | 144.72 |
| 2015 | 143.99 |
| 2014 | 36.48 |
| 2013 | -35.17 |
| 2012 | 99.54 |
| 2011 | 183.70 |
| 2010 | 14.29 |
| 2010 | 104.90 |
| 2009 | 23.56 |
| Veradigm Quarterly Free Cash Flow | |
|---|---|
| 2022-12-31 | 83.30 |
| 2022-09-30 | 67.68 |
| 2022-06-30 | 47.72 |
| 2022-03-31 | 59.32 |
| 2021-12-31 | -118.00 |
| 2021-09-30 | -168.12 |
| 2021-06-30 | -213.32 |
| 2021-03-31 | -3.80 |
| 2020-12-31 | -149.04 |
| 2020-09-30 | -7.23 |
| 2020-06-30 | -36.75 |
| 2020-03-31 | -32.98 |
| 2019-12-31 | -73.51 |
| 2019-09-30 | -65.72 |
| 2019-06-30 | -66.56 |
| 2019-03-31 | -27.63 |
| 2018-12-31 | -65.91 |
| 2018-09-30 | -23.46 |
| 2018-06-30 | -4.82 |
| 2018-03-31 | 24.63 |
| 2017-12-31 | 122.42 |
| 2017-09-30 | 25.89 |
| 2017-06-30 | 12.74 |
| 2017-03-31 | 26.94 |
| 2016-12-31 | 144.72 |
| 2016-09-30 | 90.12 |
| 2016-06-30 | 78.40 |
| 2016-03-31 | 53.06 |
| 2015-12-31 | 143.99 |
| 2015-09-30 | 81.42 |
| 2015-06-30 | 57.53 |
| 2015-03-31 | 43.11 |
| 2014-12-31 | 36.48 |
| 2014-09-30 | 3.12 |
| 2014-06-30 | 3.02 |
| 2014-03-31 | 0.25 |
| 2013-12-31 | -35.17 |
| 2013-09-30 | -24.14 |
| 2013-06-30 | -14.37 |
| 2013-03-31 | 15.06 |
| 2012-12-31 | 99.54 |
| 2012-09-30 | 69.73 |
| 2012-06-30 | 67.77 |
| 2012-03-31 | 41.90 |
| 2011-12-31 | 183.70 |
| 2011-09-30 | 101.50 |
| 2011-06-30 | 87.65 |
| 2011-03-31 | 38.79 |
| 2010-12-31 | 14.29 |
| 2010-09-30 | 57.18 |
| 2010-06-30 | 65.99 |
| 2010-05-31 | |
| 2010-03-31 | 44.49 |
| 2010-02-28 | 66.77 |
| 2009-12-31 | |
| 2009-11-30 | 28.42 |
| 2009-09-30 | 50.34 |
| 2009-08-31 | 16.67 |
| 2009-05-31 | |
| 2009-02-28 | 2.61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.476B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.476B | 53.14 |
| Tempus AI (TEM) | United States | $9.826B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.069B | 145.79 |
| Inspire Medical Systems (INSP) | United States | $4.756B | 92.38 |
| IRhythm Technologies (IRTC) | United States | $4.186B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $2.016B | 12.47 |
| Schrodinger (SDGR) | United States | $1.847B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.512B | 0.00 |
| Omnicell (OMCL) | United States | $1.460B | 31.48 |
| Azenta (AZTA) | United States | $1.232B | 57.36 |
| 10x Genomics (TXG) | United States | $1.031B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 319.00 |
| Standard BioTools (LAB) | United States | $0.456B | 0.00 |
| TruBridge (TBRG) | United States | $0.392B | 0.00 |
| Claritev (CTEV) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.294B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.208B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
| Pulmonx (LUNG) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.43 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |